CONCORDBIO
CONCORD BIOTECH LIMITEDHealthcare
LTP
1,365
CHG · %
-9.7 (-0.71%)
VOL · TODAY
68.79K
PREV CLOSE
1,374.7
Today's range1,356.4 · 1,390.9
1,365
52-week range987 · 1,801.9
1,365
Loading candles…
Concord Biotech Limited, incorporated in 1984, is an India-based biopharmaceutical company focused on research and development. The company manufactures fermentation-based active pharmaceutical ingredients (APIs) and finished formulations, specializing in complex and niche molecules such as immunosuppressants and oncology drugs. Concord operates across therapeutic areas including oncology, anti-fungal, and anti-infective treatments. It holds a significant position in the global immunosuppressant market and utilizes its core expertise in fermentation and semi-synthetic processes. The company serves both the Indian and international markets.
CONCORDBIO is not part of any active scan today.
This page is a live market overview for CONCORD BIOTECH LIMITED (CONCORDBIO) on the NSE. As a listed security, CONCORD BIOTECH LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for CONCORDBIO before placing trades on tick2trade.
As of the latest feed, CONCORDBIO last traded at ₹1,365 on NSE, down ₹9.7 (0.71%) from the previous close of ₹1,374.7. Today's session range is ₹1,356.4 – ₹1,390.9, against a 52-week band of ₹987 – ₹1,801.9. Traded volume today stands at 68.79K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for CONCORDBIO in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether CONCORDBIO is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for CONCORD BIOTECH LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in CONCORDBIO. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated CONCORDBIO option chain page linked from this overview.
// similar in healthcare314 total